Hemorrhoids Treatment Market Size & Outlook, 2025-2033

Hemorrhoids Treatment Market Size

The global hemorrhoids treatment market size was valued at USD 1.11 billion in 2024 and is projected to grow from USD 1.17 billion in 2025 to reach USD 1.82 billion by 2033, exhibiting a CAGR of 5.5% during the forecast period (2025-2033).

The market is experiencing significant growth, driven by increased awareness of the condition and the expanding availability of treatment options. Hemorrhoids, characterized by swollen veins around the anus, can cause symptoms such as pain, itching, bleeding, and swelling. These symptoms have prompted a rising demand for effective treatments. Key drivers of market expansion include an aging population, lifestyle factors, unhealthy diets, and increasing obesity rates, all contributing to the higher incidence of hemorrhoids.

Moreover, advancements in medical technology have improved access to healthcare facilities, and the growing preference for outpatient procedures is further accelerating market growth. Ongoing research and development by major players, along with the introduction of innovative treatment options, ensure the continued evolution of the market.

• For instance, in November 2024, eXroid treatment for hemorrhoids was launched across four major hospitals in Malaysia’s Klang Valley region. This non-surgical electrotherapy treatment offers patients a minimally invasive alternative to traditional surgery, making it the best option for those seeking effective and less invasive solutions.

Such innovations are expected to significantly contribute to market growth by providing patients with more accessible treatments, reducing the reliance on conventional methods.

Latest Market Trends

Rising Demand for Advanced Minimally Invasive Treatment for Hemorrhoids

The demand for advanced minimally invasive therapies for hemorrhoids is on the rise due to their benefits, such as reduced pain, quicker recovery times, and a lower risk of complications compared to conventional surgical methods. Minimally invasive treatments are becoming increasingly popular among patients who seek effective solutions with less downtime.

• For example, in December 2023, the Premier Surgical Hemorrhoid Treatment Center published an article highlighting infrared coagulation (IRC), a minimally invasive outpatient technique that uses infrared light to disrupt the blood supply to hemorrhoids, effectively reducing their size.

This growing preference for advanced treatment options, coupled with the advancement of technology, is accelerating market growth in hemorrhoid treatments as patients and healthcare providers alike opt for less invasive, more convenient alternatives.

Increasing Demand for Natural and over-the-Counter (otc) Remedies

There is a rising consumer preference for natural and over-the-counter (OTC) treatments for hemorrhoids, driven by the desire for cost-effective, non-invasive solutions. With a growing emphasis on self-care, individuals are increasingly turning to home remedies and OTC products for relief.

• For instance, in July 2024, Harvard Health Publishing highlighted natural remedies for constipation, including fiber supplements, sitz baths, witch hazel pads, and OTC creams. These solutions are often perceived as safer and more affordable, contributing to the expanding market for natural remedies and OTC treatments.

As consumers seek alternative options, this trend is fostering significant growth in the global hemorrhoids treatment market, aligning with the broader movement towards self-care and natural wellness.

To get more insights about this report Download Free Sample Report

Hemorrhoids Treatment Market Growth Factors

Increasing Prevalence of Hemorrhoids

The global prevalence of hemorrhoids is increasing, driven by lifestyle factors such as physical inactivity, poor dietary habits, obesity, and an aging population. The rising incidence of these contributing factors is leading to a higher demand for effective treatment options.

• A study published in January 2024 by Cureus reported that 50% to 85% of the global population is affected by hemorrhoids, irrespective of gender and age.

As more people experience the discomfort and complications associated with hemorrhoids, the need for accessible and efficient treatments intensifies, driving the market growth.

Rising Awareness Programs for Hemorrhoids Treatment

Increasing awareness programs and health education campaigns are essential in encouraging early diagnosis and timely treatment of hemorrhoids. As public knowledge of the condition grows, so does the demand for effective, accessible treatments.

• For instance, in May 2024, the World Gastroenterology Organization (WGO) launched its World Digestive Health Day (WDHD) 2024 campaign, which emphasized the prevention and management of gastrointestinal disorders, including hemorrhoids. Such initiatives play a vital role in improving public awareness about the condition.

The focus on education and prevention is expected to further stimulate the demand for hemorrhoid treatments, fueling continued growth in the market.

Market Restraining Factors

High Costs of Treatment for Hemorrhoid Treatment

The high cost of advanced hemorrhoid treatments, particularly minimally invasive procedures like rubber band ligation, infrared coagulation, and stapled hemorrhoidopexy, limits patient access. These treatments require specialized equipment and skilled professionals, making them expensive and less accessible for many. Moreover, elective hemorrhoid treatments are not always fully covered by insurance, forcing patients to either bear high out-of-pocket expenses or opt for less effective home remedies and OTC solutions. This trend of self-treatment, while more affordable, can lead to complications and worsen the condition, further hindering the overall growth of the hemorrhoid treatment market.

Market Opportunity

Advancement in Technologies for Hemorrhoid Treatment

The growing advancements in medical technologies are presenting significant opportunities in the global hemorrhoids treatment market. Innovative treatments, such as minimally invasive procedures and advanced pharmaceutical solutions, are gaining traction due to their effectiveness and reduced recovery times.

• For instance, in June 2023, Citius Pharmaceuticals announced positive results from its Phase 2b study of Halo-Lido (CITI-002), a promising new drug for hemorrhoid treatment. The drug demonstrated effectiveness in reducing symptoms like pain and bleeding, positioning it as a potential advanced treatment option.

As new technologies continue to emerge, offering alternative solutions to traditional therapies, the market is expected to experience sustained growth, improving treatment accessibility and outcomes for patients worldwide.

Regional Insights

North America remains the dominant player in the global hemorrhoids treatment market, driven by a combination of factors such as a high incidence rate of hemorrhoids, advanced healthcare infrastructure, and increasing demand for minimally invasive treatment options. The region benefits from substantial healthcare expenditure, heightened awareness of hemorrhoidal conditions, and a strong presence of key market players pushing for innovation in treatment solutions. Moreover, favorable reimbursement policies, along with a growing number of outpatient procedures, further contribute to the market's expansion.

U.s. Hemorrhoids Treatment Market Trends

The U.S. hemorrhoids treatment market is dominating due to its well-developed healthcare infrastructure and a rising incidence of hemorrhoids. A study published in PMC highlights that hemorrhoid disease is the fourth most common outpatient gastrointestinal diagnosis in the country. Moreover, self-reported prevalence reaches approximately 10 million cases annually, affecting 4.4% of the population. This high burden, combined with increasing demand for advanced treatments and insurance coverage, continues to drive market growth in the U.S.

Asia Pacific Hemorrhoids Treatment Market Trends

Asia-Pacific is projected to experience the highest CAGR, fueled by an increase in the prevalence of hemorrhoids, largely due to lifestyle changes, unhealthy diets, and rising obesity rates. Enhanced healthcare expenditure, coupled with growing awareness about advanced treatment options, is accelerating market growth. Moreover, the region benefits from rapid urbanization, improved healthcare infrastructure in emerging economies like China and India, and an increasing shift towards minimally invasive procedures.

• China’s hemorrhoids treatment market is expanding rapidly, driven by a large population and increasing demand for natural and alternative remedies. A research study published in Frontiers in Pharmacology in October 2023 examined the effectiveness of Traditional Chinese Medicine (TCM) in hemorrhoid management, highlighting its potential for pain relief and inflammation reduction. The integration of TCM with modern medicine, coupled with an increasing focus on minimally invasive solutions, is propelling market growth in China.
• India is witnessing rapid growth in the hemorrhoid treatment market due to a high disease prevalence and rising demand for minimally invasive procedures. In April 2024, the Thrissur Piles Clinic received recognition at the 11th Global Icon Awards for excellence in laser-based hemorrhoid treatments. As patients increasingly seek painless and quick-recovery treatments, the market is shifting toward advanced solutions like laser therapy, making India a key emerging market for hemorrhoid treatment.

Europe Hemorrhoids Treatment Market Trends

Germany is among the largest markets for hemorrhoids treatment in Europe, supported by a sophisticated healthcare system and rising demand for ambulatory treatments. In September 2024, Booking Health GmbH introduced the Rafaelo procedure, a minimally invasive technique with high success rates for treating Grade II-III internal hemorrhoids. The growing adoption of innovative, patient-friendly treatment options, along with high healthcare expenditure and insurance support, is significantly driving the hemorrhoid treatment market in Germany.

Middle East and Africa Hemorrhoids Treatment Market Trends

Saudi Arabia’s hemorrhoid treatment market is expanding, driven by rising awareness and demand for advanced medical solutions. A study published in Cureus in January 2024 reported that 16% of the general adult population in Makkah had been diagnosed with hemorrhoids. This growing patient base, coupled with the increasing adoption of sophisticated treatment methods, is fueling market expansion. Moreover, improved healthcare accessibility and government initiatives to enhance specialized care are further supporting market growth in the country.

Type Insights

The internal hemorrhoids segment holds the largest market revenue share, primarily due to their higher prevalence compared to external and prolapsed hemorrhoids. Internal hemorrhoids often go undiagnosed in their early stages as they typically don’t show noticeable symptoms, leading to a delay in treatment. As symptoms progress, the need for intervention increases.

• For example, research published in Cureus in May 2024 highlighted that internal hemorrhoids are the leading cause of lower gastrointestinal bleeding globally. This growing prevalence and late-stage diagnosis drive demand for treatment, further propelling market growth.

Treatment Insights

The surgical intervention segment dominates the market for hemorrhoids treatment due to its superior effectiveness in addressing severe and recurrent cases. Surgical procedures offer sustained relief, particularly for advanced-stage hemorrhoids that don’t respond well to conservative treatments.

• A November 2024 study published in the Journal of Clinical Medicine confirmed that surgical removal remains the gold standard for Grade III and IV internal hemorrhoids.

As more patients require surgical excision for bleeding hemorrhoids, the market’s reliance on surgical treatments continues to grow, solidifying its dominant position in the market.

End-User Insights

Hospital segment leads market due to their advanced medical infrastructure, availability of specialist surgeons, and ability to perform complex surgical procedures. With a high volume of severe cases, hospitals are equipped to manage intensive treatments such as stapled hemorrhoidopexy and hemorrhoidectomy, which are less commonly performed in outpatient settings. Moreover, hospitals provide comprehensive post-operative care, ensuring better recovery outcomes. As a result, hospitals are the primary providers of hemorrhoid treatments, contributing to their dominance in the market and further driving market growth.

Company Market Share

Key players in the industry are focusing on adopting key business strategies, such as strategic collaborations, product approvals, acquisitions, and product launches, to gain a strong foothold in the market. Companies are also investing heavily in research and development to introduce innovative, minimally invasive treatment solutions that improve patient outcomes.

Citius Pharmaceuticals, Inc.: An Emerging Player in the Global Hemorrhoids Treatment Market

Citius Pharmaceuticals is a U.S.-based biopharmaceutical company committed to the development and commercialization of innovative treatments for serious and unmet medical needs. By leveraging advanced research, cutting-edge technology, and rigorous clinical trials, the company aims to provide effective and safer treatment solutions across various therapeutic areas. Citius focuses on improving patient outcomes through novel drug formulations, minimally invasive therapies, and strategic collaborations.

List of key players in Hemorrhoids Treatment Market

1. Abbott
2. Citius Pharmaceuticals, Inc. 
3. Medfiniti
4. Servier Malaysia
5. AstraZeneca
6. Bayer AG
7. Boehringer Ingelheim International GmbH
8. Boston Scientific Corporation
9. CONMED Corporation
10. GLENMARK PHARMACEUTICALS LTD. 
11. GSK, plc
12. Olympus Corporation
13. Pfizer Inc.
14. Novartis AG
15. Takeda Pharmaceutical Company Limited

To get more findings about this report Download Market Share

Recent Developments

• March 2024 – The American Society of Colon and Rectal Surgeons (ASCRS) updated its clinical practice guidelines for managing hemorrhoids. These guidelines provide healthcare professionals with the latest recommendations on diagnosis, treatment options, and patient care strategies, ensuring that patients receive evidence-based and effective treatments.

Analyst Opinion

As per our analyst, the global hemorrhoids treatment market is set for substantial expansion, driven by the increasing prevalence of hemorrhoidal disease, greater awareness of minimally invasive procedures, and rapid advancements in pharmaceutical and medical device technologies. A key trend shaping the market is the shift toward less invasive solutions, such as infrared coagulation, hemorrhoidal artery embolization, and laser therapy, which provide effective alternatives to traditional surgeries.

Moreover, the growing preference for natural remedies, including herbal and homeopathic treatments, is influencing consumer choices and expanding treatment options. Despite these opportunities, the global market faces notable challenges. High treatment costs, particularly for advanced procedures like stapled hemorrhoidopexy and rubber band ligation, limit patient access, especially in regions with inadequate healthcare reimbursement policies.

However, ongoing investments in research and development by pharmaceutical companies and medical device manufacturers are expected to drive innovation. The introduction of novel drug formulations, enhanced surgical techniques, and improved patient care strategies will continue to propel market growth, making hemorrhoid treatment more effective, accessible, and patient-friendly in the coming years.